| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.010 | 39.229 | 67.831 | 70.532 | 88.567 | 46.837 | 63.751 | 59.639 | 125.010 | 99.244 |
| Total Income - EUR | 9.010 | 39.229 | 67.831 | 70.532 | 88.578 | 46.837 | 63.751 | 59.639 | 125.250 | 99.280 |
| Total Expenses - EUR | 5.345 | 18.614 | 28.891 | 41.036 | 69.819 | 46.338 | 51.078 | 52.720 | 72.984 | 102.735 |
| Gross Profit/Loss - EUR | 3.665 | 20.614 | 38.940 | 29.495 | 18.759 | 499 | 12.673 | 6.920 | 52.266 | -3.455 |
| Net Profit/Loss - EUR | 3.395 | 19.830 | 38.261 | 28.792 | 17.873 | 3 | 12.035 | 6.413 | 51.151 | -5.987 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Otorhinomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.434 | 47.667 | 40.291 | 33.612 | 23.248 | 17.588 | 11.759 | 9.111 | 75.229 | 58.981 |
| Current Assets | 4.021 | 257 | 10.660 | 4.219 | 3.386 | 232 | 1.577 | 612 | 9.742 | 6.220 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.250 | 0 | 48 | 995 | 294 | 60 | 57 | 40 | 2.858 | 2.525 |
| Cash | 1.771 | 257 | 10.612 | 3.223 | 3.092 | 173 | 1.519 | 573 | 6.884 | 3.695 |
| Shareholders Funds | 5.141 | 21.567 | 39.969 | 30.468 | 19.517 | 1.615 | 13.615 | 9.931 | 54.987 | 4.466 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 314 | 27.600 | 12.381 | 8.751 | 8.415 | 17.761 | 1.232 | 1.368 | 32.087 | 62.871 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Otorhinomed Srl